Literature DB >> 33681197

In vitro Anti-parasitic Activity of Pelargonium X. asperum Essential Oil Against Toxoplasma gondii.

Si-Yang Huang1,2, Na Yao1, Jia-Kang He3, Ming Pan1, Zhao-Feng Hou1, Yi-Min Fan1, Aifang Du4, Jian-Ping Tao1.   

Abstract

Toxoplasmosis is a global zoonotic disease, and one-third of the human population is chronically infected by Toxoplasma gondii. Due to the limited effectiveness and prominent side effects of the existing drugs, there is a dire need for the discovery of new therapeutic options in the treatment of toxoplasmosis. In this study, five essential oils (EO) were screened for their anti-parasitic activity against T. gondii. The cytotoxicity of essential oils was evaluated using the MTT assay on human foreskin fibroblast cells. The CC50 values of Eucalyptus globulus EO, Cupressus sempervirens EO, Citrus aurantifolia EO, Melaleuca alternifolia EO, and Pelargonium X. asperum (Pa) EO were found to be 22.74, 7.25, 15.01, 6.26, and 4.77 mg/mL, respectively. Only PaEO exhibited anti-parasitic activity, and inhibited the growth of T. gondii in a dose-dependent manner. In addition, treatment with PaEO, was found to reduce the volume of T. gondii tachyzoites and make their membrane surfaces rough. These results showed that PaEO was able to inhibit the growth of T. gondii by reducing invasion, which may be due to its detrimental effect on the ability of tachyzoites to move. These findings suggest that PaEO could be a potential anti-T. gondii drug, which may facilitate the development of new and effective treatments against toxoplasmosis.
Copyright © 2021 Huang, Yao, He, Pan, Hou, Fan, Du and Tao.

Entities:  

Keywords:  Pelargonium X. Asperum EO; Toxoplasma gondii; development; drug; natural extraction products

Year:  2021        PMID: 33681197      PMCID: PMC7930326          DOI: 10.3389/fcell.2021.616340

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  3 in total

1.  Evaluation of Origanum vulgare Essential Oil and Its Active Ingredients as Potential Drugs for the Treatment of Toxoplasmosis.

Authors:  Na Yao; Qiong Xu; Jia-Kang He; Ming Pan; Zhao-Feng Hou; Dan-Dan Liu; Jian-Ping Tao; Si-Yang Huang
Journal:  Front Cell Infect Microbiol       Date:  2021-11-22       Impact factor: 5.293

2.  The anti-Toxoplasma activity of the plant natural phenolic compound piceatannol.

Authors:  Yucong Jiang; Yuehong Shi; Dandan Hu; Xingju Song
Journal:  Front Vet Sci       Date:  2022-08-02

3.  Chemical Composition, Antioxidant, Antibacterial, and Antibiofilm Activities of Backhousia citriodora Essential Oil.

Authors:  Ann Chie Lim; Shirley Gee Hoon Tang; Noraziah Mohamad Zin; Abdul Mutalib Maisarah; Indang Ariati Ariffin; Pin Jern Ker; Teuku Meurah Indra Mahlia
Journal:  Molecules       Date:  2022-07-31       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.